4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-034017
EVP, Research & CSO sold 1,375 shares at $45.03 ($61,916)
- EVP, Research & CSO acquired 1,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-05-18 | Option exercise | +1,375 | $1.53 | $2,104 | 93,075 | D |
| Virgin Herbert EVP, Research & CSO | 2021-05-18 | Sale | −1,375 | $45.03 | $61,916 | 91,700 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2021-05-18 | Option exercise · Stock Option (Right to Buy) | −1,375 | 301,505 | D | ||
| Open-market sales · 1,375 sh · avg $45.03 · $61,916 | |||||||
Loading xslF345X03/doc4.xml…